Overview
Lobbying Costs
10,000€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2.5 Fte (10)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
ASOCIACION ESPAÑOLA DE BANCOS DE TEJIDOS (AEBT)
EU Transparency Register
454695541463-72 First registered on 16 Feb 2021
Goals / Remit
The A.E.B.T. is an altruistic scientific association whose general purpose is to take care and promote all activities related to donation, processing, conservation and transplantation of cells, tissues and organs of human origin
Main EU files targeted
Tissues and cells European Directives
Guide to the quality and safety of tissues and cell for human application
Spanish RD 09/2014Address
Head Office
AV DE LAS XUBIAS, S/N COMPLEJO HOSPITALARIO JUAN CANALEJO
A CORUÑA 15001
SPAINEU Office
Passeig Taulat, 116-126 Banc de Sang i Teixits
Barcelona 08005
SPAINWebsite
-
People
Total lobbyists declared
10
Employment time Lobbyists 25% 10 Lobbyists (Full time equivalent)
2.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
European Association of Tissue and Cells Banks ( EATCB)
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
10,000€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
0€ - 10,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
GAPP Facilitating the authorisation of preparation process for blood, tissues and cells
EuroGTP Good Practices for evaluating quality, safety and efficacy of novel tissue and cellular therapies and products
Meetings
Meetings
None declared